Detalhe da pesquisa
1.
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
N Engl J Med
; 382(12): 1124-1135, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130806
2.
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
N Engl J Med
; 382(12): 1112-1123, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130809
3.
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
Lancet
; 390(10101): 1499-1510, 2017 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750935
4.
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.
Lancet HIV
; 3(12): e569-e578, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27658864
5.
Formulation and pharmacology of long-acting rilpivirine.
Curr Opin HIV AIDS
; 10(4): 233-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26049947
6.
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.
Lancet Infect Dis
; 15(10): 1145-1155, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26201299
7.
Data reduction methods for application of fluorescence correlation spectroscopy to pharmaceutical drug discovery.
Curr Pharm Biotechnol
; 4(6): 451-62, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14683437
8.
Engineering plants for animal feed for improved nutritional value.
Proc Nutr Soc
; 62(2): 301-9, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14506877